Trial Profile

Safety, Tolerability and Gut microbIota AnalysiS of an Oral Microbiotherapy in Amyotrophic Lateral Sclerosis; an Open-label Phase 1b Pilot Trial

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 24 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MaaT 033 (Primary)
Indications Amyotrophic lateral sclerosis
Focus Adverse reactions
Acronyms IASO
Sponsors MaaT Pharma

Most Recent Events

15 Jun 2025 Status changed from active, no longer recruiting to completed.
12 May 2025 According to MaaT Pharma media release, an external Scientific Advisory Committee took place at the end of March 2025 to review the full data. The Scientific Advisory Committee provided insights regarding the best population to target in a Phase 2 trial.
12 May 2025 Final data readout results were presented in a MaaT Pharma media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com